ヘリオスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/04/27 | 1,647 | 1,670 | 1,645 | 1,666 | +11 | +0.7% | 30,600 |
| 2017/04/26 | 1,660 | 1,669 | 1,648 | 1,655 | -6 | -0.4% | 42,300 |
| 2017/04/25 | 1,645 | 1,701 | 1,621 | 1,661 | +10 | +0.6% | 47,800 |
| 2017/04/24 | 1,701 | 1,709 | 1,643 | 1,651 | -74 | -4.3% | 84,900 |
| 2017/04/21 | 1,683 | 1,746 | 1,670 | 1,725 | +72 | +4.4% | 105,300 |
| 2017/04/20 | 1,652 | 1,661 | 1,624 | 1,653 | +1 | +0.1% | 21,300 |
| 2017/04/19 | 1,610 | 1,657 | 1,610 | 1,652 | +2 | +0.1% | 26,900 |
| 2017/04/18 | 1,598 | 1,650 | 1,583 | 1,650 | +88 | +5.6% | 76,200 |
| 2017/04/17 | 1,515 | 1,626 | 1,501 | 1,562 | +17 | +1.1% | 34,700 |
| 2017/04/14 | 1,600 | 1,604 | 1,541 | 1,545 | -44 | -2.8% | 44,500 |
| 2017/04/13 | 1,430 | 1,650 | 1,430 | 1,589 | +65 | +4.3% | 139,800 |
| 2017/04/12 | 1,600 | 1,603 | 1,500 | 1,524 | -90 | -5.6% | 248,600 |
| 2017/04/11 | 1,630 | 1,630 | 1,601 | 1,614 | -40 | -2.4% | 114,100 |
| 2017/04/10 | 1,700 | 1,705 | 1,650 | 1,654 | -46 | -2.7% | 65,600 |
| 2017/04/07 | 1,702 | 1,716 | 1,638 | 1,700 | -20 | -1.2% | 100,400 |
| 2017/04/06 | 1,750 | 1,752 | 1,700 | 1,720 | -44 | -2.5% | 79,000 |
| 2017/04/05 | 1,751 | 1,770 | 1,739 | 1,764 | +13 | +0.7% | 35,700 |
| 2017/04/04 | 1,788 | 1,802 | 1,748 | 1,751 | -55 | -3% | 55,900 |
| 2017/04/03 | 1,818 | 1,818 | 1,781 | 1,806 | +7 | +0.4% | 43,300 |
| 2017/03/31 | 1,811 | 1,814 | 1,786 | 1,799 | -13 | -0.7% | 44,100 |
| 2017/03/30 | 1,761 | 1,825 | 1,752 | 1,812 | +25 | +1.4% | 133,100 |
| 2017/03/29 | 1,860 | 1,863 | 1,771 | 1,787 | +17 | +1% | 156,100 |
| 2017/03/28 | 1,750 | 1,786 | 1,705 | 1,770 | +7 | +0.4% | 84,900 |
| 2017/03/27 | 1,793 | 1,800 | 1,761 | 1,763 | -30 | -1.7% | 32,800 |
| 2017/03/24 | 1,814 | 1,814 | 1,777 | 1,793 | -11 | -0.6% | 58,900 |
| 2017/03/23 | 1,802 | 1,834 | 1,794 | 1,804 | -11 | -0.6% | 61,800 |
| 2017/03/22 | 1,801 | 1,837 | 1,801 | 1,815 | -3 | -0.2% | 67,100 |
| 2017/03/21 | 1,815 | 1,843 | 1,815 | 1,818 | +3 | +0.2% | 48,200 |
| 2017/03/17 | 1,835 | 1,850 | 1,813 | 1,815 | -26 | -1.4% | 60,000 |
| 2017/03/16 | 1,845 | 1,850 | 1,828 | 1,841 | -9 | -0.5% | 44,200 |
| 2017/03/15 | 1,850 | 1,863 | 1,840 | 1,850 | -15 | -0.8% | 65,700 |
| 2017/03/14 | 1,875 | 1,889 | 1,865 | 1,865 | -13 | -0.7% | 38,300 |
| 2017/03/13 | 1,892 | 1,919 | 1,878 | 1,878 | -43 | -2.2% | 54,900 |
| 2017/03/10 | 1,900 | 1,923 | 1,881 | 1,921 | +48 | +2.6% | 58,600 |
| 2017/03/09 | 1,885 | 1,897 | 1,872 | 1,873 | -18 | -1% | 48,100 |
| 2017/03/08 | 1,896 | 1,899 | 1,887 | 1,891 | -5 | -0.3% | 35,100 |
| 2017/03/07 | 1,905 | 1,917 | 1,895 | 1,896 | +2 | +0.1% | 43,200 |
| 2017/03/06 | 1,910 | 1,915 | 1,891 | 1,894 | -19 | -1% | 38,200 |
| 2017/03/03 | 1,911 | 1,925 | 1,902 | 1,913 | -4 | -0.2% | 36,900 |
| 2017/03/02 | 1,936 | 1,936 | 1,903 | 1,917 | ±0 | ±0% | 45,300 |
| 2017/03/01 | 1,951 | 1,951 | 1,892 | 1,917 | -4 | -0.2% | 108,600 |
| 2017/02/28 | 1,891 | 1,925 | 1,891 | 1,921 | +44 | +2.3% | 85,800 |
| 2017/02/27 | 1,868 | 1,886 | 1,856 | 1,877 | -9 | -0.5% | 79,300 |
| 2017/02/24 | 1,880 | 1,923 | 1,861 | 1,886 | -2 | -0.1% | 112,800 |
| 2017/02/23 | 1,985 | 2,046 | 1,871 | 1,888 | +53 | +2.9% | 870,400 |
| 2017/02/22 | 1,875 | 1,875 | 1,831 | 1,835 | -27 | -1.5% | 130,100 |
| 2017/02/21 | 1,885 | 1,885 | 1,854 | 1,862 | -11 | -0.6% | 57,900 |
| 2017/02/20 | 1,870 | 1,884 | 1,870 | 1,873 | +7 | +0.4% | 33,900 |
| 2017/02/17 | 1,888 | 1,900 | 1,862 | 1,866 | -34 | -1.8% | 113,600 |
| 2017/02/16 | 1,913 | 1,913 | 1,886 | 1,900 | +2 | +0.1% | 66,800 |
1851～
1900
件表示中 / 2309件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
| オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| Ｃｈｏｒｄｉａ | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム
